Skip to main content
. 2021 May 29;44:372–378. doi: 10.1016/j.clnesp.2021.05.011

Table 1.

The prevalence of vitamin D deficiency among European countries.

Country Author, Year Sample size (M/F) Age (years) Prevalence of vit D deficiency∗ (%) COVID-19 cases/M COVID-19 mortalities/M
Belgium [20] Hoge et al., 2015 697 (378/319) 20–69 51.1 55587.8 1677.4
Bosnia and Herzegovina [21] Sokolovic et al., 2016 2483 (603/1880) >18 58.7 33828.4 1234.4
Bulgaria [22] Borissova et al., 2013 2016 (948/1068) 20–80 75.8 29109.5 1090.3
Croatia [23] Barić et al., 2016 791 (660/131) 45.5 46.1 51357.7 954.9
Denmark [24] Hansen et al., 2018 2565 (1048/1517) 18–69 51.5 28224.0 224.1
Finland [25] Adebayo et al., 2020 798 (352/446) 30–64 6.9 6516.7 101.3
France [26] Deplanque et al., 2017 297 (127/170) 18–65 75.1 40145.3 992.4
Germany [27] Rabenberg et al., 2018 6995 (3360/3635) 18–79 61.5 20833.6 408.1
Greece [28] Dimakopoulos et al., 2019 1084 (410/674) ≥18 32.4 13321.4 464.2
Ireland [29] Griffin et al., 2020 17,590 ≥18 51.5 18587.1 453.0
Italy [30] Giuliani et al., 2019 74,235 (18,811/55,424) >18 33.3 34851.2 1226.5
Norway [31] Petrenya et al., 2020 4465 (2041/2424) 40–69 24.7 9143.1 80.4
Poland [32] Pludowski et al., 2016 5775 (1311/4464) 16–90 65.8 34210.9 754.5
Portugal [33] Duarte et al., 2020 3092 (1907/1995) ≥18 66.6 40569.8 677.3
Romania [34] Niculescu et al., 2017 812 >21 56.5 32865.8 819.6
Russia [35] Karonova et al., 2016 1544 (205/1294) 18–75 45.7 21648.7 390.7
Slovakia [36] Sebekova et al., 2016 578 (254/324) 5–81 15.0 32885.5 391.6
Slovenia [37] Hribar et al., 2020 125 18–64 58.2 58779.0 1297.3
Spain [38] González-Molero et al., 2011 1262 20–83 33.9 43246.9 1087.3
Sweden [39] Nälsén et al., 2020 268 (124/144) 18–80 22.4 45029.5 971.8
Switzerland [40] Guessous et al., 2012 367 (167/200) 25–70 38.2 52260.6 883.3
Ukrain [41] Povoroznyuk et al., 2012 1575 20–95 81.8 24124.3 423.8
United Kingdom [42] Jolliffe et al., 2016 222 (89/133) 48–94 64.9 36661.2 1082.9

F-Female; M-Male.

∗Prevalence of Vitamin D deficiency; Serum 25-hydroxyvitamin D3 level <20 ng/ml or <50 nmol/L; cases/M-cases per million population; mortalities/M-mortalities per million population.